JFL
AGN

Jarislowsky, Fraser Ltd’s Allergan Inc AGN Stock Holding History

Jarislowsky, Fraser Ltd’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-515,489
Closed -$110M – 148
2014
Q4 		$110M Sell
515,489
-273,364
-35% -$54.4M 0.68% 35
2014
Q3 		$141M Sell
788,853
-10,898
-1% -$1.81M 0.84% 30
2014
Q2 		$135M Sell
799,751
-32,720
-4% -$5.09M 0.76% 33
2014
Q1 		$103M Sell
832,471
-93,365
-10% -$11.4M 0.6% 41
2013
Q4 		$103M Buy
925,836
+8,071
+0.9% +$771K 0.58% 43
2013
Q3 		$83M Buy
917,765
+227,195
+33% +$20.4M 0.49% 46
2013
Q2 		$58.2M Buy
+690,570
New +$71.6M 0.35% 56

Other funds holding AGN

California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
CA
Commerzbank Aktiengesellschaft Frankfurt, Germany $4.78B AUM 25.31% 1-Year Est. Return
ECM
Everence Capital Management Goshen, Indiana $1.64B AUM 26.46% 1-Year Est. Return
HFS
HL Financial Services Louisville, Kentucky $6.5B AUM 9.56% 1-Year Est. Return
AIM
Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

Jarislowsky, Fraser Ltd's AGN Position: Q1 2015 in Review

Jarislowsky, Fraser Ltd sold out of Allergan Inc (AGN) in Q1 2015, closing a stake of 515,489 shares — an estimated $110M sold.

Jarislowsky, Fraser Ltd first reported a position in AGN in Q2 2013 and held it in 7 quarters. The position peaked at $141M in Q3 2014. 5 funds tracked by Wall St. Rank hold AGN as of Q1 2015.

  • Jarislowsky, Fraser Ltd reported no remaining Allergan Inc position as of Q1 2015 after selling out during the quarter.
  • Jarislowsky, Fraser Ltd sold 515,489 Allergan Inc shares in Q1 2015, an estimated $110M.
  • Jarislowsky, Fraser Ltd first reported a position in Allergan Inc in Q2 2013 and held it in 7 quarters.
  • Jarislowsky, Fraser Ltd's Allergan Inc position peaked at $141M in Q3 2014.
  • 5 funds tracked by Wall St. Rank held Allergan Inc as of Q1 2015.

Based on Jarislowsky, Fraser Ltd's 13F filing for Q1 2015, filed 13 May 2015.